Page last updated: 2024-09-02

selenomethylselenocysteine and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

selenomethylselenocysteine has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies

Compound Research Comparison

Studies
(selenomethylselenocysteine)
Trials
(selenomethylselenocysteine)
Recent Studies (post-2010)
(selenomethylselenocysteine)
Studies
(benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)
Trials
(benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)
Recent Studies (post-2010) (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone)
20261071,8970411

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, DY; Chung, AS; Jung, U; Kim, T1

Other Studies

1 other study(ies) available for selenomethylselenocysteine and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

ArticleYear
Se-methylselenocysteine induces apoptosis through caspase activation in HL-60 cells.
    Carcinogenesis, 2001, Volume: 22, Issue:4

    Topics: Amino Acid Chloromethyl Ketones; Anticarcinogenic Agents; Apoptosis; Caspase 3; Caspases; Cysteine; DNA Damage; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; HL-60 Cells; Humans; Immunoblotting; In Situ Nick-End Labeling; Organoselenium Compounds; Poly(ADP-ribose) Polymerases; Selenocysteine; Sodium Selenite; Time Factors

2001